A New Application for Vitamin D (Ramot)
- Summary
- The Technology:
Calcitriol (1,25-dihydroxyvitamin D3), the main hormonally active metabolite of vitamin D was found, in vitro, together with some of its synthetic analogs to have the potential to reduce the damage inflicted to normal tissue by accepted anti-cancer therapy.
Calcitriol was found to affect fundamental cellular processes such as cell proliferation, differentiation and programmed cell death in many types of cells and tissues. Calcitriol is now considered to also possess immunoregulatory and anti-cancer activities.
However, the hypercalcemic effect of calcitriol hinders its clinical use. As a result, vitamin D analogs have been developed that lack this hypercalcemic effect while retaining their “non-classical” effects on cellular physiology. One of these analogs, calcipotriol, is now used to treat psoriasis and others are under examination in many clinical trials.
The Need:
Most, if not all the therapeutic anti-cancer modalities, are accompanied by adverse side effects that exacerbate patients’ suffering and lead in many cases to non-completion of treatment protocol. It is therefore not surprising that much effort is dedicated to the search of agents to reduce these undesirable effects, while maintaining the efficacy of the anti-cancer treatment.
It should be stressed that to date there is no treatment proved to be efficient in the amelioration of the above-mentioned adverse side effects accompanying cancer therapy.
- Technology Application
- Add on treatment for accepted radiation based anti-cancer therapy.
- Others
- We found that vitamin D offered protection from programmed cell death to cells in culture, reduced the synthesis and secretion of metalloproteinases (proteolytic enzymes that cause damage to tissues when in excess) and decreased the secretion of chemokines (pro-inflammatory mediators).
The first clinical trial to test this putative beneficial effect of vitamin D analogs in cancer patients is due to start in few months
- ID No.
- 10-2007-101
- Country/Region
- Israel
For more information, please click Here
